A recent open label trial compared the efficacy of drugs currently used to lower ICP in IIH (amiloride, furosemide, spironolactone and topiramate) and found a marginal reduction in ICP with no difference between drugs [11]
For comprehensive guidance on leveraging neurodivergent strengths in professional settings, our neurodiversity workplace advantages resource provides practical strategies for career success
Published in 1993, this testing was overseen by Michael Nauck, a physician at the University of Gttingen in collaboration with Creutzfeldt, Holst and other colleagues
The primary active ingredient is gingerol, in studies, it is administered at a dosage of 200 mg/kg to in a diabetic mouse for research purposes, demonstrating activation of GLP-1 and mediation of insulin production [27]
It is used for the detoxification of electrophilic metabolites
Your provider determines which protocols are appropriate based on your diagnostic results and treatment goals